Kava in the Treatment of Generalized Anxiety Disorder: A Double-Blind, Randomized, Placebo-Controlled Study

@article{Sarris2013KavaIT,
  title={Kava in the Treatment of Generalized Anxiety Disorder: A Double-Blind, Randomized, Placebo-Controlled Study},
  author={Jerome Sarris and Con Stough and Chad A. Bousman and Zahra T Wahid and Greg Murray and Rolf Teschke and Karen Savage and Ashley Dowell and Chee H Ng and Isaac Schweitzer},
  journal={Journal of Clinical Psychopharmacology},
  year={2013},
  volume={33},
  pages={643–648}
}
Abstract Kava (Piper methysticum) is a plant-based medicine, which has been previously shown to reduce anxiety. To date, however, no placebo-controlled trial assessing kava in the treatment of generalized anxiety disorder (GAD) has been completed. A total of 75 participants with GAD and no comorbid mood disorder were enrolled in a 6-week double-blind trial of an aqueous extract of kava (120/240 mg of kavalactones per day depending on response) versus placebo. &ggr;-Aminobutyric acid (GABA) and… 
Kava for the Treatment of Generalized Anxiety Disorder RCT: Analysis of Adverse Reactions, Liver Function, Addiction, and Sexual Effects
TLDR
There was a highly significant correlation between ASEX reduction (improved sexual function and performance) and anxiety reduction in the whole sample and kava significantly increased female's sexual drive compared to placebo, with no negative effects seen in males.
Kava for generalised anxiety disorder: A 16-week double-blind, randomised, placebo-controlled study
TLDR
While research has generally supported Kava in non-clinical populations (potentially for more ‘situational’ anxiety as a short-term anxiolytic), this particular extract was not effective for diagnosed generalised anxiety disorder.
Kava for the treatment of generalised anxiety disorder (K-GAD): study protocol for a randomised controlled trial
TLDR
If this study demonstrates positive findings in support of the superiority of kava over placebo in the treatment of GAD, and also is shown to be safe, then this plant-medicine can be considered a ’first-line‘ therapy for GAD.
The effectiveness and safety of Kava Kava for treating anxiety symptoms: A systematic review and analysis of randomized clinical trials.
TLDR
Kava Kava appears to be a short-term treatment for anxiety, but not a replacement for prolonged anti-anxiety use and liver toxicity is especially possible if taken longer than 8 weeks.
Complementary and Alternative Medicine Treatments for Generalized Anxiety Disorder: Systematic Review and Meta-analysis of Randomized Controlled Trials
TLDR
Evidence about efficacy/safety of most CAM methods in GAD is limited and apparent efficacy of certain herbal preparations and body-based therapies requires further confirmation.
Kava as a Pharmacotherapy of Anxiety Disorders: Promises and Concerns
TLDR
Overall, kava has a great potential to be developed as a natural anxiolytic agent through a systematic approach, but the present form should be used with caution.
GABA‐modulating phytomedicines for anxiety: A systematic review of preclinical and clinical evidence
TLDR
Preclinical and clinical evidence is revealed for various phytomedicines modulating GABA‐pathways, with comparative anxiolytic effect to the current array of pharmaceuticals, along with good safety and tolerability profiles.
Psychological and pharmacological treatments for generalized anxiety disorder (GAD): a meta-analysis of randomized controlled trials
TLDR
A medium to large effect for empirically supported psychotherapies and medications for generalized anxiety disorder outcomes and a small effect for medications on GAD outcomes are found.
Efficacy of a freeze-dried aqueous extract of Nepeta menthoides Boiss. & Buhse in the treatment of anxiety in patients with depression: A double-blind, randomized, controlled trial
TLDR
The anxiolytic effects of N. menthoides, its lower symptom recurrence rate and its lesser side effects make this herb a potential alternative treatment for anxiety in patients with depression.
A naturalistic study of herbal medicine for self-reported depression and/or anxiety a protocol
TLDR
This study attempts to fill the gap with a longitudinal observation of individualised care as practiced by naturopaths in Australia to offer valuable insights into the effectiveness ofindividualised herbal medicine practice and provide contextualisation of data currently focused on individual herbal medicines in specific conditions.
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 39 REFERENCES
Kava in generalized anxiety disorder: three placebo-controlled trials
TLDR
In the pooled analyses, no effects were found for kava, while a significant effect in favor of placebo was observed in participants with higher anxiety at baseline, and all of the treatments were well tolerated.
The Kava Anxiety Depression Spectrum Study (KADSS): a randomized, placebo-controlled crossover trial using an aqueous extract of Piper methysticum
TLDR
The aqueous Kava preparation produced significant anxiolytic and antidepressant activity and raised no safety concerns at the dose and duration studied, and appears equally effective in cases where anxiety is accompanied by depression.
The Kava Anxiety Depression Spectrum Study (KADSS): A randomized, placebo-controlled, cross-over trial using an aqueous extract of Piper methysticum
TLDR
The aqueous Kava preparation produced significant anxiolytic and antidepressant activity and raised no safety concerns at the dose and duration studied, and appears equally effective in cases where anxiety is accompanied by depression.
Kava for the Treatment of Generalized Anxiety Disorder RCT: Analysis of Adverse Reactions, Liver Function, Addiction, and Sexual Effects
TLDR
There was a highly significant correlation between ASEX reduction (improved sexual function and performance) and anxiety reduction in the whole sample and kava significantly increased female's sexual drive compared to placebo, with no negative effects seen in males.
A Randomized, Double-Blind, Placebo-Controlled Trial of Oral Matricaria recutita (Chamomile) Extract Therapy for Generalized Anxiety Disorder
TLDR
The results suggest that chamomile may have modest anxiolytic activity in patients with mild to moderate GAD, and a positive change in all secondary outcomes in the same direction as the primary outcome measure.
Kava: A Comprehensive Review of Efficacy, Safety, and Psychopharmacology
TLDR
The current weight of evidence supports the use of kava in treatment of anxiety with a significant result occurring in four out of six studies reviewed, and more studies are required to assess comparative efficacy and safety versus established pharmaceutical comparators.
Kava extract for treating anxiety.
TLDR
The evidence presented implies that kava extract is superior compared with placebo and relatively safe as a treatment option for anxiety, and warrant further and more rigorous investigations into the efficacy and safety of kava Extract.
Kava extract versus placebo for treating anxiety
TLDR
Compared with placebo, kava extract is an effective symptomatic treatment for anxiety although, at present, the size of the effect seems small and the effect lacks robustness and is based on a relatively small sample.
An effect-size analysis of pharmacologic treatments for generalized anxiety disorder
TLDR
An effect size (ES) analysis of 21 double-blind placebo-controlled trials of medications treating DSM-III-R, DSM-IV or ICD-10 GAD using HAM-A change in score from baseline or endpoint score as the main efficacy measure found significantly higher ES for children/adolescents and for conventional drugs.
The acute effects of kava and oxazepam on anxiety, mood, neurocognition; and genetic correlates: a randomized, placebo‐controlled, double‐blind study
TLDR
A study comparing the acute neurocognitive, anxiolytic, and thymoleptic effects of a medicinal dose of kava to a benzodiazepine and explored for the first time specific genetic polymorphisms, which may affect the psychotropic activity of phytomedicines or Benzodiazepines.
...
1
2
3
4
...